Viewing Study NCT03446495


Ignite Creation Date: 2025-12-24 @ 1:37 PM
Ignite Modification Date: 2026-01-04 @ 8:43 AM
Study NCT ID: NCT03446495
Status: UNKNOWN
Last Update Posted: 2018-02-26
First Post: 2018-02-13
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: An Observational Study of Combination of Pegylated Liposomal Doxorubicin and Trabectedin in Routine Practice in Patients With Recurrent Partial-platinum Sensitive Ovarian Cancer
Sponsor: Suriya Yessentayeva
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: R279741OVC4001
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View